Cardiff Oncology, Inc.Cardiff Oncology, Inc.Cardiff Oncology, Inc.

Cardiff Oncology, Inc.

No trades
See on Supercharts

CRDF fundamentals

Cardiff Oncology, Inc. earnings per share and revenue

CRDF earnings per share for the last quarter are -0.25 USD whereas the estimation was -0.27 USD which accounts for 7.22% surprise. Company revenue for the same period amounts to 165.00 k USD despite the estimated figure of 70.00 k USD. Estimated earnings per share for the next quarter are -0.25 USD, and revenue is expected to reach 70.00 k USD. Also watch annual changes over time to get a bigger picture of CRDF earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise